Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.33 USD | -2.01% | -0.78% | +39.12% |
Mar. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
Mar. 14 | Larimar Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 42
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | - | |
Michael Celano
DFI | Director of Finance/CFO | 65 | 20-05-27 |
Noreen Scherer
CTO | Chief Tech/Sci/R&D Officer | - | 18-04-30 |
John Berman
ADM | Chief Administrative Officer | 57 | 16-12-31 |
Compliance Officer | - | 16-11-30 | |
Russell Clayton
CTO | Chief Tech/Sci/R&D Officer | - | 23-07-16 |
Gopi Shankar
PRN | Corporate Officer/Principal | - | 23-02-06 |
Comptroller/Controller/Auditor | - | 20-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Leff
BRD | Director/Board Member | 55 | 20-05-27 |
Frank Thomas
BRD | Director/Board Member | 54 | 20-05-27 |
Jeffrey Sherman
BRD | Director/Board Member | 69 | 23-10-02 |
Chief Executive Officer | 65 | - | |
Joseph Truitt
CHM | Chairman | 59 | 20-05-27 |
Thomas Hamilton
BRD | Director/Board Member | 56 | 20-05-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 63,800,017 | 62,942,921 ( 98.66 %) | 0 | 98.66 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.12% | 412M | |
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |
- Stock Market
- Equities
- LRMR Stock
- Company Larimar Therapeutics, Inc.